the burn rateI think the sales staff have some low hanging fruit lined up...like Dr Andrews associates, pro sports, etc.. the sales over the next few quarters will meet our needs, so these rumblings about dillution are unfouded.
I already consider the bladder cancer in the bag, fully funded and the right tech to become the standard of care ...but what Really gets my mo-jo-goin is the new point source delivery system. This opens the financial doors by lowering costs and time. Theralase can now afford to tackle many types of solid tumors. The tools and protocols are being refined....remember that the R+D is 6 mths ahead of the news!
The burn rate is affordable untill they expand the pipeline...after success on 1b....many months from now.